Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ATRA(ouble) in the treatment of acute promyelocytic leukemia.

Journal of biological regulators and homeostatic agents - 1 Jan 2000

Ozpolat B, Lopez-Berestein G, Mehta K

Abstract excerpt

Acute promyelocytic leukemia (APL) is a unique disease that responds to differentiation-inducing effects of all-trans-retinoic acid (ATRA). ATRA induces complete clinical remissions (CRs) in most patients and now constitutes a standard therapy in patients with APL. However, CRs induced by ATRA ar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arsenic Trioxide
Share to Arsenicals
Share to Histone Deacetylase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Promyelocytic, Acute

Share to Oxides

Share to Protein Glutamine gamma Glutamyltransferase 2

Share to Retinoic Acid Receptor alpha

Share to Transglutaminases

Source

Identifiers

PMID: 11501968

Genes

PML

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11501968-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ATRA(ouble) in the treatment of acute promyelocytic leukemia.PMID 11501968Read ↗

ATRA Resistance in Acute Promyelocytic Leukemia: Mechanisms Unveiled, Therapies ReimaginedSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment StrategiesSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment StrategiesSemantic proximity Read ↗

Acute promyelocytic leukemia: from highly fatal to highly curableSemantic proximity Read ↗

Revisiting the differentiation paradigm in acute promyelocytic leukemiaSemantic proximity Read ↗

Differentiation therapy of acute myeloid leukemia: past, present and futureSemantic proximity Read ↗

Recent advances in acute promyelocytic leukaemiaSemantic proximity Read ↗

Unlocking the potential of retinoic acid in anticancer therapySemantic proximity Read ↗

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceSemantic proximity Read ↗

The success and the challenge of all-trans retinoic acid in the treatment of cancerSemantic proximity Read ↗

Retinoic acid resistance in acute promyelocytic leukemiaSemantic proximity Read ↗

Treatment of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.